ARCHIVES

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

This article is from The Cancer Letter archive.

Vol. 34 No. 18 | May 9, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

Watson To Head Genome Research

September 30, 1988